AQR Capital Management - TONIX PHARMACEUTICALS HLDG C ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q4 2014$89,000
-1.1%
15,300
+16.8%
0.00%
Q3 2014$90,00013,1000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q3 2023
NameSharesValueWeighting ↓
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,227,832$856,0000.04%
FT Options LLC 15,000$10,0000.01%
BLUESTEIN R H & CO LLC 112,200$78,0000.01%
SABBY MANAGEMENT, LLC 203,097$142,0000.01%
TWO SIGMA SECURITIES, LLC 16,701$12,0000.00%
Klingman & Associates, LLC 10,000$7,0000.00%
TFS CAPITAL LLC 13,627$10,0000.00%
OPPENHEIMER & CO INC 75,500$53,0000.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 103,900$72,0000.00%
Virtu KCG Holdings LLC 48,827$34,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders